vs

Side-by-side financial comparison of Orion Properties Inc. (ONL) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $36.3M, roughly 1.2× Orion Properties Inc.). Orion Properties Inc. runs the higher net margin — -37.4% vs -90.4%, a 53.0% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -4.6%). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -4.9%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ONL vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.2× larger
PACB
$44.6M
$36.3M
ONL
Growing faster (revenue YoY)
PACB
PACB
+18.4% gap
PACB
13.8%
-4.6%
ONL
Higher net margin
ONL
ONL
53.0% more per $
ONL
-37.4%
-90.4%
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-4.9%
ONL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ONL
ONL
PACB
PACB
Revenue
$36.3M
$44.6M
Net Profit
$-13.6M
$-40.4M
Gross Margin
37.1%
Operating Margin
-9.3%
-92.3%
Net Margin
-37.4%
-90.4%
Revenue YoY
-4.6%
13.8%
Net Profit YoY
-45.0%
-1802.7%
EPS (diluted)
$-0.24
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ONL
ONL
PACB
PACB
Q1 26
$36.3M
Q4 25
$35.2M
$44.6M
Q3 25
$37.1M
$38.4M
Q2 25
$37.3M
$39.8M
Q1 25
$38.0M
$37.2M
Q4 24
$38.4M
$39.2M
Q3 24
$39.2M
$40.0M
Q2 24
$40.1M
$36.0M
Net Profit
ONL
ONL
PACB
PACB
Q1 26
$-13.6M
Q4 25
$-35.8M
$-40.4M
Q3 25
$-69.0M
$-38.0M
Q2 25
$-25.1M
$-41.9M
Q1 25
$-9.4M
$-426.1M
Q4 24
$-32.8M
$2.4M
Q3 24
$-10.2M
$-60.7M
Q2 24
$-33.8M
$-173.3M
Gross Margin
ONL
ONL
PACB
PACB
Q1 26
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Operating Margin
ONL
ONL
PACB
PACB
Q1 26
-9.3%
Q4 25
-101.5%
-92.3%
Q3 25
-185.8%
-101.1%
Q2 25
-67.1%
-112.8%
Q1 25
-24.4%
-1154.5%
Q4 24
-85.4%
-390.1%
Q3 24
-25.9%
-160.3%
Q2 24
-84.1%
-488.3%
Net Margin
ONL
ONL
PACB
PACB
Q1 26
-37.4%
Q4 25
-101.7%
-90.4%
Q3 25
-186.0%
-98.9%
Q2 25
-67.3%
-105.4%
Q1 25
-24.6%
-1146.8%
Q4 24
-85.4%
6.0%
Q3 24
-26.1%
-151.9%
Q2 24
-84.2%
-481.3%
EPS (diluted)
ONL
ONL
PACB
PACB
Q1 26
$-0.24
Q4 25
$-0.63
$-0.11
Q3 25
$-1.23
$-0.13
Q2 25
$-0.45
$-0.14
Q1 25
$-0.17
$-1.44
Q4 24
$-0.59
$-0.44
Q3 24
$-0.18
$-0.22
Q2 24
$-0.60
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ONL
ONL
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$10.3M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$608.5M
$5.3M
Total Assets
$1.2B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ONL
ONL
PACB
PACB
Q1 26
$10.3M
Q4 25
$22.4M
$279.5M
Q3 25
$32.6M
$298.7M
Q2 25
$17.4M
$314.7M
Q1 25
$9.4M
$343.1M
Q4 24
$15.6M
$389.9M
Q3 24
$16.6M
$471.1M
Q2 24
$24.2M
$509.8M
Total Debt
ONL
ONL
PACB
PACB
Q1 26
Q4 25
$465.0M
Q3 25
$483.0M
Q2 25
$483.0M
Q1 25
$505.0M
Q4 24
$492.0M
Q3 24
$485.0M
Q2 24
$462.0M
Stockholders' Equity
ONL
ONL
PACB
PACB
Q1 26
$608.5M
Q4 25
$623.2M
$5.3M
Q3 25
$658.8M
$36.1M
Q2 25
$728.0M
$61.5M
Q1 25
$753.5M
$91.6M
Q4 24
$763.9M
$506.6M
Q3 24
$800.9M
$453.1M
Q2 24
$816.1M
$492.7M
Total Assets
ONL
ONL
PACB
PACB
Q1 26
$1.2B
Q4 25
$1.2B
$784.1M
Q3 25
$1.2B
$803.2M
Q2 25
$1.3B
$825.5M
Q1 25
$1.3B
$860.8M
Q4 24
$1.3B
$1.3B
Q3 24
$1.4B
$1.5B
Q2 24
$1.3B
$1.5B
Debt / Equity
ONL
ONL
PACB
PACB
Q1 26
Q4 25
0.75×
Q3 25
0.73×
Q2 25
0.66×
Q1 25
0.67×
Q4 24
0.64×
Q3 24
0.61×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ONL
ONL
PACB
PACB
Operating Cash FlowLast quarter
$-19.1M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
51.4%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ONL
ONL
PACB
PACB
Q1 26
Q4 25
$23.6M
$-19.1M
Q3 25
$5.7M
$-18.7M
Q2 25
$11.6M
$-29.4M
Q1 25
$-2.2M
$-44.1M
Q4 24
$54.3M
$-30.6M
Q3 24
$13.8M
$-45.5M
Q2 24
$17.0M
$-54.3M
Free Cash Flow
ONL
ONL
PACB
PACB
Q1 26
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
FCF Margin
ONL
ONL
PACB
PACB
Q1 26
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Capex Intensity
ONL
ONL
PACB
PACB
Q1 26
51.4%
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Cash Conversion
ONL
ONL
PACB
PACB
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ONL
ONL

Rental$36.1M100%
Fee income from unconsolidated joint venture$137.0K0%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons